Less than 1 min.Read

Wuxi Biortus Biosciences: Raises US$15M in Series A Financing

November 19, 2020

Wuxi Biortus Biosciences Co. Ltd., a Wuxi, China-based leader in structural biology service for drug discovery, closed a US$15m Series A financing
The round was led by Bayland Capital
The company intends to use the funds to establish a global cryo-EM innovation center
Biortus is a full-scale contract research organization (CRO) for lead generation in drug discovery, offering services in critical aspects
The research hub is under construction at Wuxi International Life Science Innovation Campus (I·Campus) in collaboration with Wuxi Municipal Government
In the next 3 years, Biortus Cryo-EM will add at least 5 units of high-end electron microscopes to further expand its capacity